| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 622 | 394 | 25 |
| Full Text Views | 4 | 1 | 0 |
| PDF Downloads | 4 | 2 | 0 |
Erythromycin in Amebic Liver Abscess
A. J. Wilmot
A. J. Wilmot
The Amoebiasis Research Unit and the Department of Medicine, University of Natal, Durban
Search for other papers by A. J. Wilmot in
Current site
Google Scholar
PubMed
Search for other papers by A. J. Wilmot in
Current site
Google Scholar
PubMed
S. J. Powell
S. J. Powell
The Amoebiasis Research Unit and the Department of Medicine, University of Natal, Durban
Search for other papers by S. J. Powell in
Current site
Google Scholar
PubMed
Search for other papers by S. J. Powell in
Current site
Google Scholar
PubMed
R. Elsdon-Dew
R. Elsdon-Dew
The Amoebiasis Research Unit and the Department of Medicine, University of Natal, Durban
Search for other papers by R. Elsdon-Dew in
Current site
Google Scholar
PubMed
Search for other papers by R. Elsdon-Dew in
Current site
Google Scholar
PubMed
Summary
Erythromycin, 500 mg, was given every 6 hours for 10 days to six patients suffering from amebic liver abscess.
Two cases apparently responded, the remainder either failed to respond or relapsed.
By comparison with emetine and chloroquine, erythromycin is ineffective in amebic liver abscess.
Author Notes
The Amoebiasis Research Unit is sponsored by The South African Council for Scientific and Industrial Research, The Natal Provincial Administration, The University of Natal, The United States Public Health Service (Grant No. E-1592).
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 622 | 394 | 25 |
| Full Text Views | 4 | 1 | 0 |
| PDF Downloads | 4 | 2 | 0 |